A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS

Summary

This study aims to better understand how Bruton's tyrosine kinase (BTK) inhibition with remibrutinib works in hidradenitis suppurativa (HS), a complex inflammatory disease with different types of lesions.

Timeline

Start

2026-10-14

Primary completion

2028-06-19

Completion

2028-07-17

Drugs

Indications